Biblio

Found 7 results

Filters: Keyword is Registries [Clear All Filters]

2015

Andersson NW, Gustafsson LN, Okkels N, Taha F, Cole SW, Munk-Jørgensen P, Goodwin RD. 2015. Depression and the risk of autoimmune disease: a nationally representative, prospective longitudinal study.. Psychol Med. 45(16):3559-69.

2014

Owen JE, Bantum EO'Carroll, Criswell K, Bazzo J, Gorlick A, Stanton AL. 2014. Representativeness of two sampling procedures for an internet intervention targeting cancer-related distress: a comparison of convenience and registry samples.. J Behav Med. 37(4):630-41.

2013

Sørensen GVrelits, Ganz PA, Cole SW, Pedersen LA, Sørensen HToft, Cronin-Fenton DP, Garne JPeter, Christiansen PM, Lash TL, Ahern TP. 2013. Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study.. J Clin Oncol. 31(18):2265-72.

2011

Ganz PA, Habel LA, Weltzien EK, Caan BJ, Cole SW. 2011. Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort.. Breast Cancer Res Treat. 129(2):549-56.

2010

Sanders SL, Bantum EO, Owen JE, Thornton AA, Stanton AL. 2010. Supportive care needs in patients with lung cancer.. Psychooncology. 19(5):480-9.

2008

Beran TM, Stanton AL, Kwan L, Seldon J, Bower JE, Vodermaier A, Ganz PA. 2008. The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal? Ann Behav Med. 36(2):107-16.

2007

O'Connor M-F, Irwin MR, Seldon J, Kwan L, Ganz PA. 2007. Pro-inflammatory cytokines and depression in a familial cancer registry.. Psychooncology. 16(5):499-501.